Cameroon suspends use of AstraZeneca vaccine
FILE PHOTO: A medical worker prepares a dose of Oxford/AstraZeneca’s COVID-19 vaccine at a vaccination center in Antwerp, Belgium March 18, 2021. REUTERS/Yves Herman
Cameroon’s health ministry has suspended the administration of AstraZeneca’s COVID-19 vaccine it was scheduled to receive on March 20 as part of the global vaccines sharing scheme COVAX.
The ministry said in a statement on March 18 that the suspension was for precaution and prudence. It gave no further reasons for the decision or if it will go ahead and take delivery of its share of the vaccine.
Several countries have resumed use of the shots on Friday after the European Union and British regulators said the benefits outweighed any risks after reports of rare instances of blood clotting that temporarily halted inoculations.
For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.
The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link.
